A
S. M. Stieger-Vanegas and McKenzie, E. C.,
“Abdominal Imaging in Small Ruminants: Liver, Spleen, Gastrointestinal Tract, and Lymph Nodes.”,
Vet Clin North Am Food Anim Pract, vol. 37, no. 1, pp. 55-74, 2021.
D. Patel, Danelishvili, L., Yamazaki, Y., Alonso, M., Paustian, M. L., Bannantine, J. P., Meunier-Goddik, L., and Bermudez, L. E.,
“The ability of Mycobacterium avium subsp. paratuberculosis to enter bovine epithelial cells is influenced by preexposure to a hyperosmolar environment and intracellular passage in bovine mammary epithelial cells.”,
Infect Immun, vol. 74, no. 5, pp. 2849-55, 2006.
D. Patel, Danelishvili, L., Yamazaki, Y., Alonso, M., Paustian, M. L., Bannantine, J. P., Meunier-Goddik, L., and Bermudez, L. E.,
“The ability of Mycobacterium avium subsp. paratuberculosis to enter bovine epithelial cells is influenced by preexposure to a hyperosmolar environment and intracellular passage in bovine mammary epithelial cells.”,
Infection and immunity, vol. 74, no. 5, pp. 2849-55, 2006.
Y. Yamazaki, Danelishvili, L., Wu, M., Hidaka, E., Katsuyama, T., Stang, B., Petrofsky, M., Bildfell, R., and Bermudez, L. E.,
“The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells.”,
Cell Microbiol, vol. 8, no. 5, pp. 806-14, 2006.
Y. Yamazaki, Danelishvili, L., Wu, M., Hidaka, E., Katsuyama, T., Stang, B. V., Petrofsky, M., Bildfell, R. J., and Bermudez, L. E.,
“The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells.”,
Cellular microbiology, vol. 8, no. 5, pp. 806-14, 2006.
P. E. Chappell, Schneider, J. S., Kim, P., Xu, M., Lydon, J. P., O'Malley, B. W., and Levine, J. E.,
“Absence of gonadotropin surges and gonadotropin-releasing hormone self-priming in ovariectomized (OVX), estrogen (E2)-treated, progesterone receptor knockout (PRKO) mice.”,
Endocrinology, vol. 140, no. 8, pp. 3653-8, 1999.
N. Luckschander, Hall, J. A., Gaschen, F., Forster, U., Wenzlow, N., Hermann, P., Allenspach, K., Dobbelaere, D., Burgener, I. A., and Welle, M.,
“Activation of nuclear factor-kappaB in dogs with chronic enteropathies.”,
Veterinary immunology and immunopathology, vol. 133, no. 2-4, pp. 228-36, 2010.
N. Luckschander, Hall, J. A., Gaschen, F., Forster, U., Wenzlow, N., Hermann, P., Allenspach, K., Dobbelaere, D., Burgener, I. A., and Welle, M.,
“Activation of nuclear factor-kappaB in dogs with chronic enteropathies.”,
Vet Immunol Immunopathol, vol. 133, no. 2-4, pp. 228-36, 2010.
Y. Hou, Liu, M., Husted, C., Chen, C., Thiagarajan, K., Johns, J. L., Rao, S. P., and Alvira, C. M.,
“Activation of the nuclear factor-κB pathway during postnatal lung inflammation preserves alveolarization by suppressing macrophage inflammatory protein-2.”,
Am J Physiol Lung Cell Mol Physiol, vol. 309, no. 6, pp. L593-604, 2015.
Q. Li, Löhr, C. V., and Dashwood, R. H.,
“Activator protein 2alpha suppresses intestinal tumorigenesis in the Apc(min) mouse.”,
Cancer letters, vol. 283, no. 1, pp. 36-42, 2009.
Q. Li, Luo, C., Löhr, C. V., and Dashwood, R. H.,
“Activator protein-2α functions as a master regulator of multiple transcription factors in the mouse liver.”,
Hepatology research : the official journal of the Japan Society of Hepatology, vol. 41, no. 8, pp. 776-83, 2011.
H. M. Moulton, Yoshihara, P. H., Mason, D. H., Iversen, P. L., and Triozzi, P. L.,
“Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival.”,
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 8, no. 7, pp. 2044-51, 2002.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Barbara-Burnham, L., and Young, L. S.,
“Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige mice.”,
Antimicrobial agents and chemotherapy, vol. 40, no. 3, pp. 546-51, 1996.
C. B. Inderlied, Barbara-Burnham, L., Wu, M., Young, L. S., and Bermudez, L. E.,
“Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages.”,
Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1838-43, 1994.
L. E. Bermudez, Kolonoski, P., Young, L. S., and Inderlied, C. B.,
“Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection.”,
Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1844-8, 1994.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., Aralar, P., Wu, M., and Young, L. S.,
“Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium.”,
Antimicrobial agents and chemotherapy, vol. 45, no. 1, pp. 217-22, 2001.